Assessing the Knowledge of HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Vaccination, and Practice Scope among Saudi Dental Students in the Western Region

被引:3
|
作者
Alsharif, Maha T. [1 ]
Alsahafi, Elham [2 ]
机构
[1] King Abdulaziz Univ, Fac Dent, Dept Oral Diagnost Sci, Jeddah 21589, Saudi Arabia
[2] Umm Al Qura Univ, Fac Dent, Dept Basic & Clin Oral Sci, Mecca 24382, Saudi Arabia
关键词
HPV; oropharyngeal SCC; HPV vaccine; dental students; FEMALE UNIVERSITY-STUDENTS; HUMAN-PAPILLOMAVIRUS HPV; CANCER; AWARENESS; EPIDEMIOLOGY; ATTITUDES; RISK; HEAD; MEN;
D O I
10.3390/healthcare12090905
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
(1) Background: Human papillomavirus (HPV) infection is significantly associated with oropharyngeal squamous cell carcinoma (HPV-OPSCC), which is one of the fastest-growing cancer incidences globally. Dental practitioners play a crucial role in the primary and secondary prevention of HPV-OPSCC. There is little known about dental students' awareness regarding HPV-OPSCC and HPV vaccination, as well as their intention to promote 'primordial prevention' among their patients. HPV vaccine, and the extent of their professional responsibilities. (2) Methods: This cross-sectional study was conducted in the western region of Saudi Arabia and involved undergraduate dental students (n = 688) from six public and private dental schools. Participants were requested to complete a sequential-section anonymous online survey, with 257 successfully completing all sections of the questionnaire. The association between participant characteristics and HPV-OPSCC, HPV vaccination awareness ratings, and perceived engagement in prevention were analyzed using ANOVA and chi-squared testing. A binary logistic regression analysis was conducted to examine the variables linked to these outcomes. (3) Results: Generally, the overall level of awareness of HPV-OPSCC and HPV vaccination was acceptable, with an average score of 53.44 +/- 29.3 out of 100. However, a significant knowledge gap was observed, with 53% of respondents being unaware of the common sites for HPV-OPSCC and 63.8% being uninformed of the appropriate age for HPV vaccination. Females and those with a prior history of sexually transmitted diseases (STDs) had considerably higher levels of HPV vaccination knowledge (p < 0.05). The participants showed a favorable attitude towards their responsibility of informing patients about HPV-OPSCC and advocating HPV immunization. (4) Conclusions: This study underscores the need to enhance dental students' understanding of HPV-OPSCC and HPV immunization, enabling them to effectively engage in primary and secondary preventative efforts against HPV-OPSCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma (vol 134, 106131, 2022)
    Morse, Ryan T.
    Beaty, Brian
    Scanga, Lori
    Blumberg, Jeff
    Patel, Samip
    Yarbrough, Wendell G.
    Lumley, Catherine
    Hackman, Trevor
    Shen, Colette
    Gupta, Gaorav P.
    Chera, Bhisham S.
    ORAL ONCOLOGY, 2022, 135
  • [42] Advances in Surgical Therapy for HPV-Associated Squamous Cell Carcinoma
    Collin F. Mulcahy
    Neil D. Gross
    Current Otorhinolaryngology Reports, 2022, 10 : 475 - 482
  • [43] HPV-independent adenocarcinoma has poorer prognosis than squamous cell carcinoma and HPV-associated adenocarcinoma, and HPV-associated adenocarcinoma has similar prognosis with squamous cell carcinoma
    Kwon, Hyo Eon
    Ahn, Seong Bin
    Kim, Hye Jin
    Cho, Eun Hye
    Im, Do Hwa
    Kim, Da Hyun
    Kim, Young Nam
    Lee, Kyung Bok
    Sung, Moon Su
    Jeong, Dae Hoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A105 - A105
  • [44] Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma
    Wotman, Michael
    Gold, Brandon
    Takahashi, Mai
    Draper, Lindsey
    Posner, Marshall
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (02) : 208 - 217
  • [45] Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma
    Michael Wotman
    Brandon Gold
    Mai Takahashi
    Lindsey Draper
    Marshall Posner
    Current Otorhinolaryngology Reports, 2022, 10 : 208 - 217
  • [46] Advances in Surgical Therapy for HPV-Associated Squamous Cell Carcinoma
    Mulcahy, Collin F.
    Gross, Neil D.
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (04) : 475 - 482
  • [47] Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
    Zhou, Xin
    Wang, Xiaoshen
    BIOMEDICINES, 2022, 10 (08)
  • [48] Prognostic Impact of Retropharyngeal Lymphadenopathy in HPV-associated Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Chemoradiation
    Bhattasali, O.
    Ryoo, J. J.
    Thompson, L. D. R.
    Iganej, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E412 - E412
  • [49] Factors to Consider When Contemplating Posttreatment Surveillance for Survivors of HPV-Associated Oropharyngeal Squamous Cell Carcinoma
    Swegal, Warren C.
    Eisele, David W.
    Fakhry, Carole
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2019, 145 (10) : 908 - 910
  • [50] Circulating Tumor HPV16 DNA as a Biomarker of Tumor Genomics and Disease Control in HPV-associated Oropharyngeal Squamous Cell Carcinoma
    Gupta, G. P.
    Kumar, S.
    Marron, D.
    Amdur, R. J.
    Hayes, D. N.
    Weiss, J.
    Grilley-Olson, J.
    Zanation, A.
    Hackman, T.
    Zevallos, J. P.
    Patel, S.
    Weissler, M.
    Parker, J. S.
    Mendenhall, W. M.
    Chera, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1310 - 1311